BioSpace News Archive

The healthcare industry has made significant progress when it comes to efficiency and scope in the last several years, yet many complex issues remain unsolved.

Nymi Inc. is excited to welcome Michael Brown, Rear Admiral, United States Navy (Retired), and Founder & President of Spinnaker Security LLC, as their first Advisory Board Member.

Coined as the medical device industry’s “cheat sheet”.

On the heels of winning the Security Industry Association’s (SIA) New Product Showcase award for the Best Emerging Technology in 2020, BioConnect is thrilled to be selected into the MaRS Momentum Program. It is a launchpad for global powerhouse companies. It is an exclusive program designed to support the executives of high growth companies on their way to exceeding $100 million in revenue in the next five years. The program,

Akerna (Nasdaq: KERN), a leading enterprise software and compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), has exercised its option to acquire the remaining 20% of solo sciences inc.,

Lincoln Property Company (“LPC”), in partnership with MetLife Investment Management is pleased to announce that construction has commenced on a 140,000 square foot state-of-the-art life science/office facility at 300 Third Avenue in Waltham, MA.

Global Health Expert at RTI International, Pia MacDonald, MPH, PhD, is using her experience from past epidemics to track the potential spread and impact of the COVID-19 pandemic.

Curi Bio , a leading developer of human iPSC-based platforms for drug discovery, has acquired Dana Solutions, a pioneer in the application of artificial intelligence and machine learning to in vitro cell-based assays. “Curi Bio is developing human-relevant platforms integrating human cells, systems, and data to accelerate the discovery of new medicines,” said Curi CEO Michael Cho. “With the acquisition of Dana’s AI/ML te

CancerConnect a leading online destination for cancer patients and their caregivers seeking information and support in the wake of a cancer diagnosis experienced a doubling of patient traffic during first three months of the COVID-19 pandemic to over 80,000 unique monthly visitors

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, today announced it is naming its tendon and ligament portfolio under the new brand AlloConnex™.